Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.19|
|52 Week High||AU$0.16|
|52 Week Low||AU$0.36|
|1 Month Change||-2.56%|
|3 Month Change||-33.33%|
|1 Year Change||5.56%|
|3 Year Change||-35.59%|
|5 Year Change||-50.00%|
|Change since IPO||-96.22%|
Recent News & Updates
Auditors Are Concerned About Health and Plant Protein Group (ASX:HPP)
The harsh reality for Health and Plant Protein Group Limited ( ASX:HPP ) shareholders is that its auditors...
Is Health and Plant Protein Group (ASX:HPP) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|HPP||AU Food||AU Market|
Return vs Industry: HPP exceeded the Australian Food industry which returned 1.5% over the past year.
Return vs Market: HPP underperformed the Australian Market which returned 20.2% over the past year.
Stable Share Price: HPP is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: HPP's weekly volatility (10%) has been stable over the past year.
About the Company
Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America. It offers its products under the Royal Hawaiian Orchards and MacFarms brands. The company was formerly known as Buderim Group Limited and changed its name to Health and Plant Protein Group Limited in December 2020.
Health and Plant Protein Group Fundamentals Summary
|HPP fundamental statistics|
Is HPP overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HPP income statement (TTM)|
|Cost of Revenue||AU$26.52m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.086|
|Net Profit Margin||-29.23%|
How did HPP perform over the long term?See historical performance and comparison
Is Health and Plant Protein Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate HPP's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate HPP's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: HPP is unprofitable, so we can't compare its PE Ratio to the Australian Food industry average.
PE vs Market: HPP is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HPP's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HPP is good value based on its PB Ratio (1.1x) compared to the AU Food industry average (1.6x).
How is Health and Plant Protein Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health and Plant Protein Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Health and Plant Protein Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HPP is currently unprofitable.
Growing Profit Margin: HPP is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HPP is unprofitable, but has reduced losses over the past 5 years at a rate of 13.6% per year.
Accelerating Growth: Unable to compare HPP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HPP is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (45.2%).
Return on Equity
High ROE: HPP has a negative Return on Equity (-50.64%), as it is currently unprofitable.
How is Health and Plant Protein Group's financial position?
Financial Position Analysis
Short Term Liabilities: HPP's short term assets (A$19.6M) do not cover its short term liabilities (A$23.8M).
Long Term Liabilities: HPP's short term assets (A$19.6M) exceed its long term liabilities (A$5.2M).
Debt to Equity History and Analysis
Debt Level: HPP's debt to equity ratio (89%) is considered high.
Reducing Debt: HPP's debt to equity ratio has increased from 60.4% to 89% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HPP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HPP has less than a year of cash runway if free cash flow continues to grow at historical rates of 3.6% each year.
What is Health and Plant Protein Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HPP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HPP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HPP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HPP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: HPP is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HPP's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Health and Plant Protein Group has no CEO, or we have no data on them.
Experienced Management: HPP's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Experienced Board: HPP's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.8%.
Health and Plant Protein Group Limited's employee growth, exchange listings and data sources
- Name: Health and Plant Protein Group Limited
- Ticker: HPP
- Exchange: ASX
- Founded: 1941
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Market Cap: AU$23.336m
- Shares outstanding: 122.82m
- Website: https://www.hppgroup.com
Number of Employees
- Health and Plant Protein Group Limited
- 159 Coronation Drive
- Level 3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/16 07:03|
|End of Day Share Price||2021/10/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.